How Much Is Enough? The Continuing Debate on the Axillary Lymph Node Dissection in Breast Cancer

How Much Is Enough? The Continuing Debate on the Axillary Lymph Node Dissection in Breast Cancer
Veronica C Shim, MD, FACS

 

Spring 2007 - Volume 11 Number 2

https://doi.org/10.7812/TPP/06-085

Since the Halsted radical mastectomy was introduced in 1894,1 breast cancer treatment has undergone major changes. More than a century later, breast conserving surgery is now accepted in the treatment armamentarium of early breast cancer. However, the role of axillary lymph node dissection (ALND) in breast cancer treatment continues to be controversial. The persistent question in this debate is whether we should abandon axillary lymph node evaluation in breast cancer management; I believe we cannot.

 

etoc emailClick here to join the E-TOC list or text TPJ to 22828. You will receive an Email notice with the Table of Contents of each issue.

CME

The Kaiser Permanente National CME Program designates this journal-based CME activity for 4 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Circulation

27,000 print readers per quarter, 15,350 eTOC readers, and in 2018, 2 million page views of TPJ articles in PubMed from a broad international readership.

The Permanente Press

The Permanente Press publishes The Permanente Journal and books related to healthcare. For information about subscriptions, missing issues, billing, subscription renewal, and back issues, Email: permanente.journal@kp.org.


ISSN 1552-5775 Copyright © 2019 thepermanentejournal.org.

All Rights Reserved.